Background: Chronic kidney disease (CKD) is a health problem associated with high morbidity and mortality. Mineral and bone disorders are complications of CKD with a risk of fractures and cardiovascular disease. Mesenchymal stem cells can differentiate into osteoblasts and regulate their regulation by a network of cytokines and transcription factors. Objective: Analyzing differences in osteoblastogenesis of adipose mesenchymal stem cells in CKD patients and healthy people. Methods: The study sample was adipose mesenchymal stem cells from CKD patient undergoing hemodialysis and healthy people. Osteoblastogenesis was assessed by measuring the concentrations of transforming growth factor-beta 1 (TGF-beta 1), bone morphogenetic protein-2 (BMP-2), and (DKK-1) in culture media. The Elisa method measured the concentration of these parameters on days 4, 7, 14, and 21. Data were analyzed using an independent t-test and post hoc test with p-value <0.05. Result: There was a significant difference in CKD patients with increasing TGF-beta 1 on day 4 (t = 2.821; 95% CI = 30,498-199,727; p = 0.010) and decreased on day 14. In the BMP-2 parameter, there was an increase on day 7 (t = 4.291; 95% CI = 0.289-0.831; p <0.001). Similar conditions were also found in the DKK-1 parameter, increasing on the 7th day, but there was no significant difference (p = 0.583). Conclusion: Osteoblastogenesis in adipose mesenchymal stem cells in CKD patients differs from that in healthy individuals. Osteoblasts fail in maturation and cause failure in matrix mineralization.
1 July 2024 in Biomolecular and Health Science Journal
Introduction: Chronic kidney disease (CKD) is a condition characterized by kidney damage or reduced function lasting at least 3 months. Hemodialysis (HD) is a key treatment for CKD, replacing kidney function in fluid and acid–base electrolyte balance, metabolic waste removal, and blood pressure management. Intradialytic weight gain (IDWG) is a common HD complication, with patients with limited systolic blood pressure having the highest risk of intradialytic hypotension (IDH)-related death. This research examined IDWG patterns in patients on regular HD. Methods: A prospective, observational study of 40 end-stage renal disease patients on regular HD twice a week at Dr. Soetomo Hospital was conducted for 3 months. Every patient received HD for at least 3 months. Data from purposive sampling. Statisticians used IBM SPSS ® Statistics 25. Results: A total of 20 out of 40 IDWG subjects experienced IDH. In the IDH group, the percentage of women was 11 (55%) people, the mean age of the research subjects was 49.9 ± 9.70 years, the mean duration on HD of the research subjects was 70.5 ± 43.78 months, and the mean IDWG percentage (IDWG%) of the research subjects was 5.36 ± 1.1. By statistical analysis, a correlation value of P = 0.008 was obtained. Conclusion: There was a correlation between IDWG% and the incidence of IDH, with or without confounding factors such as gender, age, and duration of HD. The higher the percentage value of IDWG, the higher the IDH incidence rate.
1 March 2026 in Journal of Pharmacy & Pharmacognosy Research
Context: Chronic kidney disease (CKD) imposes a significant global healthcare burden. Pharmacist-led interventions have been proposed to improve pre-dialysis CKD management, yet comprehensive quantitative evidence remains limited. Aims: To evaluate the effects of pharmacist-led interventions on clinical outcomes, medication adherence, patient knowledge, and drug-related problems (DRPs) in adults with pre-dialysis CKD. Methods: A systematic search of PubMed, Scopus, Web of Science, and Crossref (2010–2024) was conducted in accordance with preferred reporting items for systematic reviews and a meta-analysis (PRISMA) guideline. Eligible randomized controlled trials (RCTs) and quasi-experimental studies were included. Meta-analysis was performed using RevMan 5.4.1. Results: Twelve studies (4,945 patients) were included. Pharmacist-led interventions significantly reduced DRPs (mean difference: -0.23; 95% CI: -0.37 to -0.08; p=0.002) and improved patient knowledge (mean difference: 0.80; 95% CI: 0.64–0.95; p<0.001). No significant changes were observed in estimated glomerular filtration rate, blood pressure, or medication adherence. Conclusions: Pharmacist-led interventions reduced drug-related problems and improved patient knowledge in pre-dialysis CKD. However, no significant changes were observed in eGFR, blood pressure, or medication adherence. Clinically, pharmacists help prevent adverse events and enhance adherence, supporting long-term care quality. Future studies should examine whether combined interventions, including lifestyle and dietary support, can translate these benefits into measurable clinical outcomes.
22 June 2026 in Malaysian Journal of Ophthalmology
Introduction: This study aimed to compare the thickness of the retinal ganglion cell layer (GCL) and the ganglion cell-inner plexiform layer (GC-IPL) in haemodialysis (HD) patients with and without diabetes mellitus (DM). Methods: This was a single-centre cross-sectional study conducted in Indonesia. Comprehensive ocular examinations and demographic information were gathered from 110 eyes of 110 HD patients. The sample was divided into DM and non-DM groups. Optical coherence tomography was used to analyse GCL and GC-IPL thickness. The independent t-test or Mann-Whitney test was used to examine the difference between the two groups, and a p-value of less than 0.05 was deemed significant. Results: We analysed 110 eyes of 110 HD patients and divided them into the DM group (27, 24.5%) and non-DM group (83, 75.5%). The average duration of HD in the DM group was lower at 30.8 months than in the non-DM group of 50.6 months (p < 0.05). Hypertension was found in 24 (88.8%) patients in the DM group and 66 (79.5%) in the non-DM group (p < 0.05). HD patients with DM group showed significantly thinner GCL in all sectors (p < 0.05) and significantly thinner GC-IPL in 4 sectors (p < 0.05). In the hypertension cases, GCL and GC-IPL showed significant difference between the two groups (p < 0.05). Conclusion: HD patients with DM demonstrated thinner GCL and GC-IPL. This finding indicates the importance of integrated ophthalmic evaluation in HD patients to prevent further damage of neural retina.